Carolinas Wealth Consulting LLC Apellis Pharmaceuticals, Inc. Transaction History
Carolinas Wealth Consulting LLC
- $557 Million
- Q4 2024
A detailed history of Carolinas Wealth Consulting LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 39 shares of APLS stock, worth $731. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$731
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
286Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$231 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$229 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$223 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$190 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$180 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.06B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...